Clinical Trials Browser

Phase 3 × Uterine Cervical Neoplasms × 1 year × Clear all

NCT03556839 2026-04-21

BEATcc

Phase 3 Completed

Carcinoma, Uterine Cervical Neoplasms

NCT05581121 2026-04-17

PAROLA

Phase 3 Recruiting

Adenocarcinoma, Uterine Cervical Neoplasms, Carcinoma, Adenosquamous

NCT06459180 2026-04-17

TroFuse-020

Phase 3 Recruiting

Uterine Cervical Neoplasms

NCT07216703 2026-04-17

TroFuse-036

Phase 3 Recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

NCT02466971 2026-04-13

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

Phase 3 Active not recruiting

450 enrolled 11 charts

Uterine Cervical Neoplasms, Vaginal Neoplasms

NCT07418749 2026-04-06

A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer

Phase 3 Recruiting

Uterine Cervical Neoplasms

NCT03979014 2026-03-31

NOVEL

Phase 3 Completed

Uterine Cervical Neoplasms, Neoplasms

NCT03256916 2026-02-24

NELCER

Phase 3 Completed

Uterine Cervical Neoplasms

NCT04697628 2026-02-24

innovaTV 301

Phase 3 Completed

502 enrolled 18 charts 2 FDA

Uterine Cervical Neoplasms

NCT04221945 2026-02-20

KEYNOTE-A18

Phase 3 Completed

1,060 enrolled 30 charts 2 FDA

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

NCT01279135 2026-02-06

PARCER

Phase 3 Completed

Uterine Cervical Neoplasms

NCT03635567 2026-02-04

KEYNOTE-826

Phase 3 Completed

617 enrolled 29 charts 2 FDA

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

NCT07164534 2026-02-04

CHOC-LATE

Phase 3 Not yet recruiting

Uterine Cervical Neoplasms

NCT00980954 2025-12-31

Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy

Phase 3 Completed

236 enrolled 28 charts

Uterine Cervical Neoplasms

NCT04157985 2025-12-11

Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors

Phase 3 Completed

DermatologicGastrointestinalGenitourinaryGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Melanoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Cholangiocarcinoma

NCT06007586 2025-12-04

Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients

Phase 3 Completed

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Vomiting, Endometrial Neoplasms

NCT04537156 2025-11-21

Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Phase 3 Active not recruiting

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Condylomata Acuminata

NCT04982237 2025-11-19

A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

Phase 3 Active not recruiting

Uterine Cervical Neoplasms

NCT07230626 2025-11-17

SYS6002 vs Chemotherapy in Recurrent or Metastatic Cervical Cancer

Phase 3 Not yet recruiting

Uterine Cervical Neoplasms

NCT02834637 2025-09-10

DoRIS

Phase 3 Active not recruiting

Uterine Cervical Neoplasms

NCT04906993 2025-09-09

Camrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic Cervical Cancer

Phase 3 Active not recruiting

Uterine Cervical Neoplasms

NCT04534075 2025-09-08

FIDURA

Phase 3 Completed

GastrointestinalGenitourinaryGynecologic

Anus Neoplasms, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Flatulence, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms

NCT00092534 2025-08-01

FUTURE II

Phase 3 Completed

12,167 enrolled 23 charts

Uterine Cervical Neoplasms, Condylomata Acuminata

NCT05056402 2025-07-22

An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old

Phase 3 Active not recruiting

Uterine Cervical Neoplasms, Condylomata Acuminata

NCT05078047 2025-06-05

MOIO

Phase 3 Recruiting

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & Neck

Esophageal Squamous Cell Carcinoma, Carcinoma, Basal Cell, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT02446652 2025-05-29

Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer

Phase 3 Withdrawn

Uterine Cervical Neoplasms

NCT01101451 2025-05-23

Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery

Phase 3 Completed

340 enrolled 13 charts

Uterine Cervical Neoplasms

NCT06459687 2025-05-14

Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer

Phase 3 Recruiting

Uterine Cervical Neoplasms